Wells Fargo
IRWD icon

Wells Fargo’s Ironwood Pharmaceuticals IRWD Stock Holding History

Wells Fargo’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-47,282
Closed -$58K – 6438
2017
Q3 		$58K Buy
+47,282
New +$651K ﹤0.01% 5416

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wells Fargo's IRWD Position: Q2 2026 in Review

Wells Fargo increased its Ironwood Pharmaceuticals (IRWD) stake by 1,950% in Q2 2026, buying an estimated $4.42M and bringing the position to 1,206,198 shares worth $5.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2831.

Wells Fargo first reported a position in IRWD in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.9M in Q3 2021. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Wells Fargo held 1,206,198 shares of Ironwood Pharmaceuticals worth $5.08M as of Q2 2026.
  • Wells Fargo bought 1,147,348 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $4.42M.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #2831 holding.
  • Wells Fargo first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Wells Fargo's Ironwood Pharmaceuticals position peaked at $16.9M in Q3 2021.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.